LinkedIn co-founder Reid Hoffman just raised $25 million to take on cancer with AI
LinkedIn (MSFT) co-founder and venture capitalist Reid Hoffman on Monday launched an AI startup aimed at discovering new treatments for cancer.
Guo’s Conviction Partners adds Mike Vernal as GP, raises $230M fund
When in mid-2022 Sarah Guo left Greylock to launch her own AI-focused fund, Conviction Partners, she indicated that she was ...
Reid Hoffman-backed AI drug discovery startup Manas AI launches with $24.6M
Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in initial funding. The investment was led by General Catalyst and Manas AI ...
Is AI Revolutionary or Hype? What If It Is Both?
There is substance to the hype cycle if you know where to look, according to investors at the WSJ CIO Network Summit.
Greylock’s Asheem Chandna on spotting game-changing founders, and never losing a dime
Asheem Chandna has spent 22 years in venture capital, and he’s never lost money.
Outsourcing-pharma16d
Manas AI bags $24.6 million to turbocharge drug discovery
Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.
Goodbye, Golden Handcuffs: Inside The Partner Exodus Rippling Across Venture Capital
A wave of partners are leaving blue-chip firms to join emerging funds or start their own — some still unannounced. Meet ...